* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 1-Copy of CHAPTER 1
Survey
Document related concepts
Neuropsychopharmacology wikipedia , lookup
Orphan drug wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Compounding wikipedia , lookup
Plateau principle wikipedia , lookup
Pharmacognosy wikipedia , lookup
List of comic book drugs wikipedia , lookup
Neuropharmacology wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Prescription costs wikipedia , lookup
Drug design wikipedia , lookup
Theralizumab wikipedia , lookup
Drug discovery wikipedia , lookup
Transcript
PHT 415 BASIC PHARMACOKINETICS Course Instructor: Prof. Dr. Hanaa Elsaghir Assistant lecturers: Iman Elfakeah and Fay Elkathery Text: Hand book of basic pharmacokinetics, Applied Biopharmaceutics and pharmacokinetics and lab notes Grading: Quizzes (5 pt), Midterm (12.5 pt), Final (20 pt), Practical (10 pt), Attendance (2.5 pt) Lectures: Sunday- Tuseday from 9_10 Office Hours: Sunday and Wednesday 10-12 Email: [email protected] Objectives of the first lecture (intravenous dose ) The student will be able to: • Define Pharmacokinetics, intravascular and extravascular administration, absorption, disposition, distribution, metabolism, excretion, first-pass effect, enterohepatic cycling, compartment • Define the meaning of half- life, elimination rate constant, first order process, volume of distribution, clearance, renal clearance, and fraction excreted unchanged drug. • • • Estimate the values of half-life, elimination rate constant, volume of distribution, and renal clearance from plasma or blood concentrations of a drug following an IV dose Estimate the values of half-life, elimination rate constant, and fraction excreted unchanged from urinary excretion data following an intravenous dose Estimate the value of renal clearance of a drug from combined plasma and urine data . • Calculate the concentration of drug in the plasma and the amount of drug in the body with time following an intravenous dose, given values for the pharmacokinetic parameters. • Some concepts and definition: • 1-Measurement of a drug in the body is limited usually to blood or plasma. • 2- Blood receives drug from the site of administration as well as carries it to all the organs, including those in which the drug acts and those in which it is eliminated. • 3- Sites of administration may be classified as either intravascular or extra vascular. • 4- Intravascular administration refers to the placement of a drug directly into the blood, either intravenously or intra-arterially • 5-Extravascular include the oral, sublingual, buccal, intramuscular, subcutaneous, dermal, pulmonary, and rectal routes • 6- Drug administered extravascularly must be absorbed: no absorption step is required when a drug is administered intravascularly. • Disposition • Once absorbed, a drug is distributed to the various organs of the body. Distribution is influenced by how well each organ is perfused with blood, organ size, binding of drug within blood and in tissues, and permeability of tissue membranes • The two principal organs of elimination, the liver and the kidneys • The kidneys are the primary site for excretion of the chemically unaltered, or unchanged, drug. • The liver is the usual organ for drug metabolism; however, the kidneys and other organs can also play an important metabolic role for certain drugs • • • • • The liver may also secrete unchanged drug into the bile. The lungs are, or may be, an important route for eliminating volatile substances e.g. gaseous anesthetics. Absorption Absorption is defined as the process by which unchanged drug proceeds from site of administration to site of measurement within the body. Absorption is not restricted to oral administration. It occurs as well following IM, SC, and other extra vascular routes of administration • • • • Monitoring intact drug in blood or plasma offers a useful means of assessing the entry of drug into the systemic circulation. Disposition May be defined as, all processes that occur subsequent to the absorption of a drug. By definition, the components of disposition are distribution and elimination. Elimination is the irreversible loss of drug from the site of measurement • Excretion is the irreversible loss of chemically unchanged drug. • Metabolism is the conversion of one chemical species to another... • Elimination occurs by two processes, excretion and metabolism. • Mass balance of a drug and related material with time in the body: • Dose= amount of drug at absorption site+ amount of drug in the body + amount of drug excreted +amount of metabolite in the body + amount of metabolite eliminated • Biopharmaceutics • Interrelationship of the physicochemical properties of the drug, dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption • Pharmacokinetics • Kinetics of drug absorption, distribution, and elimination (i.e excretion and metabolism) • It involve experimental aspect and theoretical aspect • Measurement of drug concentrations • Sensitive, accurate, and precise analytical methods are available for the direct measurements of drugs in biologic samples, such as milk, plasma, and urine. • Sampling of biologic specimens • Invasive methods such as sampling blood, spinal fluid , synovial fluid , tissue biopsy • Noninvasive methods include sampling of urine, saliva,feces, expired air,or any biologic material that can be obtained without parenteral or surgical intervention • Drug concentrations in blood, plasma, or serum • The most direct approach to assessing pharmacokinetics of the drug in the body is the measurement of drug concentration in the whole blood, serum or plasma. • Serum • Whole blood is allowed to clot and the serum is collected from the supernatant after centrifugation • Plasma • Is obtained from supernatant of centrifuged whole blood to which an anticoagulant, such as heparin Plasma level- time curve 1-Is generated by measuring the drug concentration in plasma samples taken at various time intervals after a drug product is administered 2- The concentration of drug in each plasma sample is plotted on rectangular coordinate graph against the corresponding time at which the plasma sample was removed. Drug concentrations in urine Measurement of drug in urine is an indirect method to ascertain the bioavailability of a drug. The rate and extent of drug excreted in the urine reflects the rate and extent of systemic drug absorption. • Measurement of drug in feces may reflect drug that has not been absorbed after oral dose or may reflect drug that has been expelled by biliary secretion after systemic absorption. • Significance of measuring plasma drug concentrations • allows for the adjust men of the drug dosage in order to individualize and optimize therapeutic drug regimens • Guide to the progress of the diseased state and enable the investigator to modify the drug dosage accordingly. • Monitoring the concentration of drugs in the blood or plasma ascertains that the calculated dose actually delivers the plasma level required for therapeutic effect • Checking the plasma drug level is a responsive method of monitoring the course of therapy • Experimental aspect involves, the development of biological sampling techniques, analytical methods for measurement of drugs and metabolites and procedures that facilitate data collection • Theoretical aspect involves the development of pharmacokinetic models that predict drug disposition after administration • Pharmacodynamics • Refer to the relationship between drug concentrations at the site of action ( receptor) and pharmacologic response including biochemical, and physiologic effect that influence the interaction of drug with receptor PK and PD PK is the study of what the body does to a drug PD is the study of what a drug does to the body DRUG THERAPY Duration of Drug Therapy: Single Dose: such as to relieve a headache For the Rest of the Patient’s Life: such as in chronic diseases (epilepsy, diabetes) DOSAGE REGIMEN The manner in which a drug is taken is called a Dosage Regimen Duration of Drug Therapy and Dosage regimen will depend on the therapeutic objective. Objectives of taking a drug are : Cure, Mitigation, Prevention SUCCESSFUL DRUG THERAPY By optimally balancing the desirable and undesirable effects Accurate diagnosis is made Drug of choice Knowledge of clinical state of patient Understanding the pharmaco-therapeutic management of the disease Answer the questions How much? How often? and How long? Answers to Questions?????? How much? Recognizes that the magnitude of the therapeutic and toxic responses is a function of the dose given. How often? Recognizes the importance of time, in that the magnitude of the effect eventually declines with time following a single dose of drug. How long? Recognizes that a cost (in terms of side effects, toxicity, economics) is incurred with continuous drug administration. In the Past Questions were answered by trial and error, i.e. the dose, interval between doses, and route of administration were selected and the patient’s progress was followed. This empirical approach established many dosage regimens but left many questions unanswered!!!!!! This empirical approach did not contribute toward establishing a safe, effective dosage regimen of another drug, i.e. did not help us understand how drugs work? Event that follows drug administration Plasm a Theophylline Concentration (m g/L) 6 5 4 3 2 1 0 0 12 24 36 48 Hours Plasma conc of theophylline after an oral dose of 600-mg Application of Pharmacokinetics Rarely is a drug placed at its site of action, most drugs are given orally and yet they act in the brain, heart, or elsewhere!!!! Which means a drug has to move from the site of administration to the site of action. Therefore to administer drugs optimally, knowledge is needed not only of the mechanisms of drug absorption, distribution, and elimination but also the kinetics of these processes, that is PK Following Drug Administration 2 phases can be distinguished Pharmacokinetic Phase: in which the adjustable elements of dose, dosage form, frequency, and route of administration are related to drug level-time relationships in the body. Pharmacodynamic Phase: in which the conc of drug at the site of action(s) is related to the magnitude of the effect(s) produced. Aimes of PK and PD Knowing the PK and PD of drugs will aid in designing a dosage regimen to achieve the therapeutic objective. OPTIMIZE PATIENT DRUG THERAPY BY MONITORING PK&PD RESPONSES Advantages over the Empirical Approach 1- Distinction can be made between PK and PD causes of an unusual drug response. 2- Information gained about the PK of one drug can help in anticipating the PK of another drug. 3- Understanding the PK of a drug often explains the manner of its use. 4- Knowing the PK of a drug aids the clinician in determining the optimal dosage regimen for a patient and in predicting what may happen when a dosage regimen is changed. An Approach to the Design of a Dosage Regimen Pharmacokinetics Dosage Regimen Pharmacodynamics Plasma Concentration Site of Action Effects Where to Measure Concentration? Rarely can the concentration of the drug at the site of action be measured directly; instead the concentration is measured at an alternative and more accessible site, the plasma. What is then an optimal dosage regimen? It is the one that maintains the plasma concentration of a drug within the therapeutic window and then maintaining this concentration by replacing the amount of drug lost with time. Initial and Maintenance Dose Two different regimens A and B, B=2A Plasma conc Regimen B Therapeutic Window Regimen A Time Drug-Drug Interaction Interactions that result in a change in PK of a drug could be due to: Stimulation of drug metabolizing enzymes therefore increasing drug loss. Inhibition of drug metabolizing enzymes therefore slowing drug elimination and increasing its concentration in the blood. Interference with drug absorption. DRUG IS A VERY COMPLEX SYSTEM WHAT WE WILL DO IN THIS CLASS? Although the details of drug kinetics are complicated, it is fortunate that we can often approximate drug kinetic processes using “SIMPLE MATHEMATICAL MODELS”. The use of PK equations, rather than the derivation of the equations will be taught in this class.